Sodium hyaluronate is the sodium salt of hyaluronic acid, a naturally occurring glycosaminoglycan found in the extracellular matrix of connective tissues, synovial fluid, and the vitreous humor of the eye. It is a viscoelastic, biocompatible, non-immunogenic substance used in various medical and cosmetic applications due to its unique ability to retain moisture, lubricate joints, and promote tissue healing. In pharmaceuticals, it serves as an active pharmaceutical ingredient (API) in ophthalmic solutions, intra-articular injections for osteoarthritis, topical formulations for wound care, and as a dermal filler in aesthetic medicine.
Chemical Structure
Sodium hyaluronate is a linear polysaccharide, composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, linked by β-1,3 and β-1,4 glycosidic bonds. Its molecular formula is (C14H20NO11Na)n, and its molecular weight varies greatly depending on the degree of polymerization—from low molecular weight (50,000 Da) to high molecular weight (>1 million Da).
This molecule is highly hydrophilic, capable of absorbing up to 1,000 times its weight in water, which contributes to its viscoelastic and cushioning properties. In medical applications, its molecular weight and concentration determine its functional behavior—ranging from lubricating drops to space-filling joint injections.
Sodium Hyaluronate-Based Medicines List
- Hyalgan® – Intra-articular injection for knee osteoarthritis pain relief.
- Viscosupplement® – Synovial fluid replacement therapy for degenerative joint disease.
- Blink® Tears – Ophthalmic drops for dry eye syndrome.
- Gengigel® – Oral gel containing sodium hyaluronate for gum tissue healing.
- Thealoz Duo® – Eye drops for ocular surface protection in dry eye and oxidative stress.
- Juvéderm® Hydrate – Cosmetic injectable used for facial hydration and volumizing.
- OcuSoft® – Artificial tear formulation containing sodium hyaluronate.
- Hylase® – Wound healing gel with sodium hyaluronate to promote dermal repair.
Mechanism of Action
“Sodium hyaluronate” exerts its effects through physical and biochemical mechanisms depending on its application:
- In ophthalmology, it stabilizes and restores the tear film, lubricates the ocular surface, and protects corneal epithelial cells.
- In orthopedics, it acts as a viscosupplement, restoring the viscosity of synovial fluid in joints, providing shock absorption, and reducing friction, thus relieving pain in osteoarthritis.
- In wound healing, sodium hyaluronate forms a hydrated matrix that facilitates cell migration, angiogenesis, and collagen synthesis, accelerating tissue repair.
- In aesthetic medicine, it serves as a dermal filler, adding volume and hydration to skin layers and smoothing wrinkles.
Biologically, sodium hyaluronate interacts with CD44 receptors and other cell surface markers, influencing cell proliferation, migration, and inflammation regulation.
Pharmacokinetics
Pharmacokinetics vary based on the route of administration and molecular weight:
- Absorption: Poor systemic absorption when applied topically or ocularly; remains localized at the site of application.
- Distribution: When injected intra-articularly or intradermally, it stays localized, forming a protective matrix.
- Metabolism: Degraded by hyaluronidase enzymes into oligosaccharides and monosaccharides.
- Elimination: Metabolites are removed by the lymphatic system or via renal excretion.
- Half-life: Varies by molecular weight and site. For intra-articular use, the half-life can range from 1 to 3 days; topical or ocular forms are cleared within hours unless cross-linked or stabilized.
Therapeutic Uses
| Indication | Therapeutic Role of Sodium Hyaluronate |
|---|---|
| Osteoarthritis (knee, hip) | Intra-articular injection to reduce joint pain and stiffness |
| Dry eye syndrome | Lubricates and hydrates ocular surface as artificial tear |
| Corneal epithelial damage | Promotes corneal healing and protection |
| Wound healing (chronic ulcers, burns) | Maintains moist wound environment to accelerate healing |
| Gingivitis and oral lesions | Forms a healing barrier and reduces inflammation in gums |
| Dermal hydration and anti-aging | Injectable filler for restoring skin volume and elasticity |
| Post-operative ocular care | Supports corneal recovery following eye surgeries |
| Nasal or sinus dryness | Used in nasal sprays to hydrate mucosa and reduce crusting |
Side Effects
Sodium hyaluronate is generally well-tolerated, with a low incidence of adverse effects due to its biocompatibility. However, specific reactions may occur depending on the route:
- Intra-articular (joint injection):
- Joint swelling
- Localized pain or stiffness
- Injection-site inflammation (transient)
- Rarely, pseudoseptic reaction
- Ophthalmic (eye drops):
- Mild burning or stinging
- Blurred vision (temporary)
- Sensation of a foreign body in the eye
- Dermal (cosmetic fillers):
- Bruising, redness, swelling at injection site
- Rare granuloma formation
- Hypersensitivity (very rare)
- Topical (wound or mucosal):
- Minimal local irritation
- Hypersensitivity reactions (extremely rare)
Drug Interactions
Sodium hyaluronate has minimal drug interactions, as it is not systemically absorbed and does not interfere with metabolic enzyme systems. However, potential considerations include:
- Concurrent use with corticosteroids (intra-articular): Often combined for synergistic relief, though excessive steroid use may impair tissue healing.
- Topical antibiotic creams: No interference, but application sequence should be considered to maintain skin contact time.
- Ophthalmic medications: Should be spaced out (e.g., 5–10 minutes apart) when used with other eye drops to avoid dilution or flushing.
- Hyaluronidase enzyme: Used intentionally to reverse or degrade injected hyaluronate fillers in aesthetics.
Safety Considerations
Sodium hyaluronate has a high safety profile due to its endogenous origin and non-antigenic properties. However, some safety points should be noted:
- Pregnancy and lactation: Considered safe in topical and ophthalmic forms; injectable forms should be used under medical supervision.
- Pediatric use: Safe in eye drops and wound care; injectable use not routinely recommended.
- Allergy considerations: Rare hypersensitivity, especially in cross-linked or animal-derived formulations.
- Autoimmune conditions: Patients with autoimmune joint disorders may have altered responses to intra-articular injections.
Sterile technique must be used for injectable forms to avoid contamination and inflammation.
Regulatory Status
Sodium hyaluronate is approved by global regulatory agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), MHRA, and TGA for multiple clinical uses. It is classified as a medical device in certain formulations (e.g., dermal fillers or viscoelastic surgical aids) and as a drug in others (e.g., eye drops, intra-articular injections).
In the cosmetic industry, sodium hyaluronate is widely accepted in dermal fillers and skincare products, with regulation depending on the product’s classification as a device or drug. Prescription-only variants exist for intra-articular and intradermal injection, while over-the-counter formulations are available for ocular, mucosal, and topical use.
